Week In Review: Akeso Stages $335 Million HK IPO For Mono-/Bi-Specific Antibodies

, , Comments Off on Week In Review: Akeso Stages $335 Million HK IPO For Mono-/Bi-Specific Antibodies

AkesoBio staged a $335 million Hong Kong IPO and climbed 50% higher in its first trading session. CStone Pharma announced that China’s NMPA has accepted its NDA …
( read original story …)